Learn about how adoptive cell therapies (ACT) work, current progress and obstacles to using ACTs effectively in solid cancers, and clinical trials studying ACTs in people with metastatic breast cancer.
- When to Use Surgery & Radiation to the Breast
- HER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
- Imaging Tests for People with Stage IV Breast Cancer
- PD-L1 Biomarker for Immunotherapy
- What is ER-Low Breast Cancer?
- HER2 Positive Metastatic Breast Cancer Research Update
- Recent FDA Approvals for Metastatic Breast Cancer
- The Tumor Microenvironment
- What is Your Tumor’s Mutation Burden?
- Triple-Negative Breast Cancer Update
- Tips for Reading Cancer News
- What is a Tumor Agnostic Therapy?
- Treating Brain Metastases
- New FDA Approval: A PI3K Inhibitor
- Best of MBC Research News (2018-2019)
- What is Oligometastatic Breast Cancer?
- Getting to the Target: Antibody Drug Conjugates
- First Immunotherapy Approved for MBC
- Liquid Biopsies: More than a Blood Test?
- Get the Latest News on PARP Inhibitors
- New Research Presented at San Antonio
SEARCH OUR SITE
for past articles or specific information.